Filed pursuant to Rule 497(a)
Registration No. 333-256733
Rule 482ad
[TEXT OF COMMUNICATION SENT VIA BLOOMBERG]
***THIS EMAIL MAY BE FORWARDED TO EXTERNAL
CLIENTS***
***THIS DOCUMENT MAY ONLY BE SENT EXTERNALLY WITH THE
DISCLAIMERS INCLUDED***
**THIS DOCUMENT IS NOT FOR DISTRIBUTION IN THE EEA, UK, CANADA,
JAPAN OR BRAZIL**
**THIS DOCUMENT IS NOT FOR DISTRIBUTION IN CHINA (PRC) EXCEPT IN
COMPLIANCE WITH ALL APPLICABLE LAWS AND REGULATIONS**
**ONLY FOR DISTRIBUTION TO INVESTORS WHO FALL WITHIN ONE OR MORE
OF THE CATEGORIES OF INVESTORS UNDER SECTION 708 OF THE
AUSTRALIAN CORPORATIONS ACT TO WHOM AN OFFER MAY BE MADE
WITHOUT DISCLOSURE UNDER PART 6D.2 OF THE AUSTRALIAN
CORPORATIONS ACT.**
Ares Capital Corp
(“ARCC” / NASDAQ)
Ares Capital Corporation is a management investment
company. The Company seeks to generate both income and capital
appreciation through debt and equity investments by primarily
investing in U.S. middle market companies.
Joint Lead Book-Running Managers: Morgan Stanley, BofA
Securities, UBS Investment Bank, RBC Capital Markets, Wells Fargo
Securities
Joint Book-Running Managers: Keefe, Bruyette &
Woods, A Stifel Company, Raymond James
Co-Managers: Goldman Sachs & Co. LLC, Janney Montgomery
Scott, J.P. Morgan, Oppenheimer & Co.
Stabilization Agent: Morgan Stanley
B&D: Morgan Stanley
Base Offering Size: 9,000,000 Shares (100% Primary)
Greenshoe: 15% (100% Primary)
Launch Date: Thursday, January 12, 2023
(Post-Close)
Expected Pricing Date: Thursday, January 12, 2023
(Post-Close)
***THIS DOCUMENT MAY ONLY BE SENT EXTERNALLY WITH THE
DISCLAIMERS INCLUDED***
**THIS DOCUMENT IS NOT FOR DISTRIBUTION IN THE EEA, THE UK, CANADA,
JAPAN OR BRAZIL**
**THIS DOCUMENT IS NOT FOR DISTRIBUTION IN CHINA (PRC) EXCEPT IN
COMPLIANCE WITH ALL APPLICABLE LAWS AND REGULATIONS**
**ONLY FOR DISTRIBUTION TO INVESTORS WHO FALL WITHIN ONE OR MORE OF
THE CATEGORIES OF INVESTORS UNDER SECTION 708 OF THE
AUSTRALIAN CORPORATIONS ACT TO WHOM AN OFFER MAY BE MADE
WITHOUT DISCLOSURE UNDER PART 6D.2 OF THE AUSTRALIAN
CORPORATIONS ACT.**
The foregoing is a preliminary summary of terms and is subject to
change. Please contact your representative for more
details.
Investors are advised to carefully consider the investment
objective, risks, charges and expenses of Ares Capital before
investing. The preliminary prospectus supplement dated January 12,
2023, together with an accompanying prospectus dated June 3,
2021, which have been filed with the Securities and Exchange
Commission, contain this and other information about Ares Capital
and should be read carefully before investing.
The information in the preliminary prospectus supplement and the
accompanying prospectus, and in this announcement, is not complete
and may be changed. The preliminary prospectus supplement, the
accompanying prospectus and this announcement are not offers to
sell any securities of Ares Capital and are not soliciting an offer
to buy such securities in any jurisdiction where such offer and
sale is not permitted.
A shelf registration statement relating to these securities is
on file with and has been declared effective by the Securities and
Exchange Commission. The offering may be made only by means of a
preliminary prospectus supplement and an accompanying prospectus.
Copies of the preliminary prospectus supplement (and accompanying
prospectus) may be obtained from Morgan Stanley & Co. LLC, 180
Varick Street, 2nd Floor, New York, NY 10014, Attn: Prospectus
Department; BofA Securities, NC1-004-03-43, 200 North College
Street, 3rd floor, Charlotte NC 28255-0001, Attn: Prospectus
Department, or email dg.prospectus_requests@bofa.com; UBS
Securities LLC at 1285 Avenue of the Americas, New York, New York,
10019, Attn: Prospectus Department, by telephone at (888) 827-7275,
or by email: ol-prospectus-request@ubs.com; RBC Capital Markets,
LLC at 200 Vesey Street, 8th Floor, New York, New York, 10281,
Attn: Prospectus Department, or by telephone at (877) 822-4089; or
Wells Fargo Securities at 500 West 33rd Street, New York, New York,
10001, Attn: Equity Syndicate Department, by calling toll free
1-800-326-5897, or by e-mail at
cmclientsupport@wellsfargo.com.
ANY DISCLAIMERS OR OTHER NOTICES THAT MAY APPEAR AFTER THIS
MESSAGE ARE NOT APPLICABLE TO THIS COMMUNICATION AND SHOULD BE
DISREGARDED. SUCH DISCLAIMERS OR OTHER NOTICES WERE AUTOMATICALLY
GENERATED AS A RESULT OF THIS COMMUNICATION BEING SENT VIA
BLOOMBERG OR ANOTHER EMAIL SYSTEM.
Ares Capital (NASDAQ:ARCC)
Historical Stock Chart
From Sep 2023 to Oct 2023
Ares Capital (NASDAQ:ARCC)
Historical Stock Chart
From Oct 2022 to Oct 2023
